Down-regulation of PPAR-γ by AGEs thus directly impairs osteoclast differentiation, while upregulation of PPAR-γ levels by adrenomedullin 2 has been shown to largely restore osteogenesis impaired in vitro by AGEs and in vivo by diabetes in rats (Wang et al., 2021). This evidence concerns the gene PPARG and diabetes mellitus.